Clinical Trial Update: Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France

View source ↗

Summary

A completed French clinical trial reports characteristics and outcomes of acute myeloid leukemia patients treated with maintenance therapy using oral azacitidin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Onureg (azacitidine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Acute Myeloid Leukemia (AML) | Status: COMPLETED